Investigating the Mechanism of Action of Antitumour Benzoprims
KRAS is one of the most frequently mutated oncogenes, with activating mutations occurring in ~ 20% of all human cancers, including >90% of pancreatic cancer, ~40% of colorectal cancer (CRC) and ~30% of non-small cell lung cancer (NSCLC). Until recently, KRAS inhibitors have not been successful cl...
| Main Author: | |
|---|---|
| Format: | Thesis (University of Nottingham only) |
| Language: | English |
| Published: |
2024
|
| Subjects: | |
| Online Access: | https://eprints.nottingham.ac.uk/78346/ |